Outlook Therapeutics, Inc. (OTLK) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 27M |
| Enterprise Value | 49.12M |
| P/E Ratio | -0.53 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | -104.05 |
| Price/Book Ratio | -8.52 |
| Enterprise/Revenue | -110.23 |
| Enterprise/EBITDA | -2.06 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 52.55 |
| Operating Margin | 47.83 |
| Return On Assets | -2.33 |
| Return On Equity | 2.22 |
| Revenue | 1.41M |
| Revenue/Share | -0.01 |
| Gross Profit | 657,205 |
| EBITDA | -63.58M |
| Net Income | -62.42M |
| Diluted EPS | -1.79 |
| Total Cash | 11.24M |
| Total Cash/Share | 0.08 |
| Total Debt | 18.43M |
| Total Debt/Equity | -1.77 |
| Current Ratio | 0.81 |
| Book Value Per Share | -0.08 |
| 52-Week Change | -78.21 |
| 52-Week High | 3.39 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 1.27 |
| Moving Average 200 Days | 0.9 |
| Average Volume | 27.3M |
| Shares Outstanding | 187M |
| % Held by Institutions | 13.11 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 14, 2024 |